Mrv1909 04182314182D 7 4 0 0 0 0 999 V2000 0.8250 -1.6500 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 0.8250 1.6500 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 0.8250 -0.8250 0.0000 S 0 5 0 0 0 0 0 0 0 0 0 0 0.8250 0.0000 0.0000 Mo 0 0 0 0 0 0 0 0 0 0 0 0 0.8250 0.8250 0.0000 S 0 5 0 0 0 0 0 0 0 0 0 0 1.6500 -0.0000 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.0000 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 4 6 2 0 0 0 0 4 7 2 0 0 0 0 M CHG 4 1 1 2 1 3 -1 5 -1 M END > DB17641 > drugbank > [NH4+].[NH4+].[S-][Mo]([S-])(=S)=S > InChI=1S/Mo.2H3N.4S/h;2*1H3;;;;/q;;;;;2*-1/p+2 > PQNOIAHNKHBLRN-UHFFFAOYSA-P > H8MoN2S4 > 260.27 > 261.862438 > 0 > 15 > -6.537925725516575e-10 > 14.293677329414066 > 1 > 0 > 0 > 0 > diammonium (sulfanidyldisulfanylidenemolybdenio)sulfanide > 1.5672 > 0 > 2 > 0 > 2 > 0.0 > 37.7352 > 0 > 1 > tiomolibdate diammonium > 1 > DB17641 > investigational > Ammonium tetrathiomolybdate > Ammonium molybdenum sulfide ((nh4)2mos4); Coprexa; Diammonium tetrathiomolybdate; Molybdate(2-), tetrathioxo-, ammonium (1:2), (t-4)-; Molybdate(2-), tetrathioxo-, diammonium, (t-4)-; Tiomolibdate diammonium $$$$